Transcranial Low Intensity Focused Ultrasound Neuromodulation as a Probe to Study Human Emotion and Cognitive Function
Not Applicable
Not yet recruiting
- Conditions
- Depressive Disorder, Major
- Registration Number
- NCT05194332
- Brief Summary
The purpose of this study is to assess the low-intensity focused ultrasound pulsation (LIFUP) neuromodulation on emotion processing in healthy individuals, and to assess the overall safety of the LIFUP to stimulate or inhibit brain activity in healthy volunteers.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
- Must be right-handed
- Must be illicit drug-free at the time of scanning as appropriate (verified by negative urine drug screen)
- Must be healthy (without medical, neurological, psychiatric illness)
- Must be psychotropic medication free (≥ 14 days)
Exclusion Criteria
- Must not be a smoker
- Females must not be pregnant or nursing
- Must not suffer from claustrophobia
- Must not meet exclusion criteria for MRI scanning (i.e., non-fixed magnetizable objects)
- Must not have ongoing, chronic, or relapsing/remitting medical, psychiatric,or neurological illness as determined by a combination of history, medical record, and/or examination.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Changes in amygdala activity indicated by functional magnetic resonance imaging (fMRI) scan blood oxygen-level-dependent (BOLD) signal baseline, 5 mins post-LIFUP sonication Changes in brain resting state functional network as indicated by fMRI scan connectivity measures baseline, 10-20 mins post-LIFUP sonication
- Secondary Outcome Measures
Name Time Method Change in performance on Reward Task baseline, 1-hour post-LIFUP sonication Tolerability of LIFUP sonication as assessed number of adverse events baseline, immediately after LIFUP sonication
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie LIFUP's effect on amygdala activity in emotion processing?
How does transcranial focused ultrasound compare to TMS in treating major depressive disorder?
Are there specific biomarkers that predict individual response to LIFUP neuromodulation in emotional regulation?
What adverse events are associated with transcranial ultrasound stimulation of the amygdala in healthy volunteers?
What combination therapies involving LIFUP show promise for enhancing cognitive and emotional function in depression?
Trial Locations
- Locations (1)
The University of Texas Health Science Center at Houston
🇺🇸Houston, Texas, United States
The University of Texas Health Science Center at Houston🇺🇸Houston, Texas, United StatesAndrea Boscutti, MDContact713-486-2622Andrea.Boscutti@uth.tmc.eduJuliana FigueiredoContact